Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Releases "Xperience" Subscription Service (click to learn more) Star Diamond: High Modelled Diamond Prices and High Proportions of Type IIa Diamonds (click to learn more) Northstar Discovers Large Near Surface EM Conductor SE of Cam Copper Mine (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lattice Biologics Ltd LBLTF


Primary Symbol: V.LBL.H

Healthcare Biotechnology
Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post... see more

Recent & Breaking News (TSXV:LBL.H)

Lattice Biologics Ltd. Announces Management Cease Trade Order

Business Wire January 30, 2018

Lattice Biologics Ltd. Announces Change in Director and Change in Status of Chief Operating Officer

Business Wire December 22, 2017

Lattice Biologics Ltd. Reports Third Quarter 2017 Highlights

Business Wire August 29, 2017

Notice of Lattice Biologics Ltd. Third Quarter 2017 Financial Results Conference Call

Business Wire August 25, 2017

Lattice Biologics Ltd. Completes Debt to Equity Conversion and Issues Shares for Services

Business Wire July 17, 2017

Lattice Biologics Ltd. Announces Change in Director and Chairman of Scientific Advisory Board

Business Wire July 6, 2017

Lattice Biologics Ltd. Announces Move to Belgrade, Montana

Business Wire June 26, 2017

Lattice Biologics Ltd. Announces Change to Location of Its Annual General and Special Meeting

MarketWire Canada June 20, 2017

Grenville Strategic Royalty Announces Completion of Transaction to Restructure Lattice Biologics Investment

GlobeNewswire June 14, 2017

Lattice Biologics Ltd. Announces Completion of Transaction to Reduce Royalty and Debt Obligations

MarketWire Canada June 13, 2017

Lattice Biologics Ltd. Receives Multi-Year American Association of Tissue Banks Re-Accreditation

MarketWire Canada June 1, 2017

Lattice Biologics Ltd. Appoints Chief Operating Officer

MarketWire Canada May 31, 2017

Lattice Biologics Ltd. Reports Second Quarter 2017 Highlights

MarketWire Canada May 30, 2017

Notice of Lattice Biologics Ltd. Second Quarter 2017 Financial Results Conference Call

MarketWire Canada May 17, 2017

Lattice Biologics Announces Completion of Private Placement

MarketWire Canada May 15, 2017

Lattice Biologics Announces Agreement to Successfully Reduce Royalty and Debt Obligations

MarketWire Canada April 26, 2017

Lattice Biologics Closes Fifth Tranche of Private Placement and Extends Funding Raise for an Additional 30 Days

MarketWire Canada April 4, 2017

Service Provider Loyalty Remains Strong as Lattice Biologics Issues Shares for Services and Announces Planned Debt-to-Equity Conversion

MarketWire Canada March 20, 2017

Lattice Biologics Extends Private Placement

MarketWire Canada March 7, 2017

Lattice Biologics Ltd. Reports First Quarter 2017 Highlights

Marketwired March 1, 2017